Evidence map›Paper›PMID 26733828›Full record

ArticleFrontiers in behavioral neuroscience2015

Comparison of Visuospatial and Verbal Abilities in First Psychotic Episode of Schizophrenia Spectrum Disorder: Impact on Global Functioning and Quality of Life.

Mabel Rodriguez, Filip Spaniel, Lucie Konradova, Katerina Sedlakova, Karolina Dvorska, Jitka Prajsova, Zuzana Kratochvilova, David Levcik, Kamil Vlcek, Iveta Fajnerova

Open access · goldAbstract read
In one paragraph

Article in Frontiers in behavioral neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mabel RodriguezNational IT System of Mental Health and Brain Monitoring, National Institute of Mental Health Klecany, Czech Republic.
Filip SpanielNational IT System of Mental Health and Brain Monitoring, National Institute of Mental HealthKlecany, Czech Republic; Department of Psychiatry and Medical Psychology, Third Faculty of Medicine, Charles University in PraguePrague, Czech Republic.
Lucie KonradovaNational IT System of Mental Health and Brain Monitoring, National Institute of Mental Health Klecany, Czech Republic.
Katerina SedlakovaNational IT System of Mental Health and Brain Monitoring, National Institute of Mental HealthKlecany, Czech Republic; Department of Psychiatry and Medical Psychology, Third Faculty of Medicine, Charles University in PraguePrague, Czech Republic.
Karolina DvorskaDepartment of Psychiatry and Medical Psychology, Third Faculty of Medicine, Charles University in Prague Prague, Czech Republic.
Jitka PrajsovaNational IT System of Mental Health and Brain Monitoring, National Institute of Mental Health Klecany, Czech Republic.
Zuzana KratochvilovaNational IT System of Mental Health and Brain Monitoring, National Institute of Mental Health Klecany, Czech Republic.
David LevcikDepartment of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of Sciences Prague, Czech Republic.
Kamil VlcekNational IT System of Mental Health and Brain Monitoring, National Institute of Mental HealthKlecany, Czech Republic; Department of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of SciencesPrague, Czech Republic.
Iveta FajnerovaNational IT System of Mental Health and Brain Monitoring, National Institute of Mental HealthKlecany, Czech Republic; Department of Psychiatry and Medical Psychology, Third Faculty of Medicine, Charles University in PraguePrague, Czech Republic; Department of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of SciencesPrague, Czech Republic.
National Institute of Mental Health · CZCharles University · CZCzech Academy of Sciences, Institute of Physiology · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDeficit in visuospatial functions can influence both simple and complex daily life activities. Despite the fact that visuospatial deficit was reported in schizophrenia, research on visuospatial functions as an independent entity is limited. Our study aims to elucidate the impact of visuospatial deficit in comparison with verbal deficit on global functioning and quality of life in the first psychotic episode of schizophrenia spectrum disorder (FES). The significance of clinical symptoms and antipsychotic medication was also studied.

methodsThirty-six FES patients and a matched group of healthy controls (HC group) were assessed with a neuropsychological battery focused on visuospatial (VIS) and verbal (VERB) functions. Using multiple regression analysis, we evaluated the cumulative effect of VERB and VIS functions, psychiatric symptoms (PANSS) and antipsychotic medication on global functioning (GAF) and quality of life (WHOQOL-BREF) in the FES group.

resultsThe FES group demonstrated significant impairment both in VIS and VERB cognitive abilities compared to the HC group. Antipsychotic medication did not significantly affect either VIS or VERB functioning. PANSS was not related to cognitive functioning, apart from the Trail Making Test B. In the FES group, the GAF score was significantly affected by the severity of positive symptoms and VERB functioning, explaining together 60% of GAF variability. The severity of negative and positive symptoms affected only the Physical health domain of WHOQOL-BREF. The degree of VERB deficit was associated with both Physical and Psychological health. Although we did not find any relation between VIS functioning, GAF, and WHOQOL-BREF, a paradoxical finding emerged in the Environment quality domain, where a worse quality of the environment was associated with better VIS functioning.

conclusionsOur results suggest that the deficit in VIS functions is an integral part of cognitive deficit in schizophrenia spectrum disorders, rather than a side effect of symptomatology or antipsychotic medication. Moreover, VERB functioning was a better predictor of GAF and WHOQOL-BREF than VIS functioning. Given the findings of negative or missing effect of VIS deficit on WHOQOL-BREF and GAF, the accuracy of these measures in evaluating the impact of global cognitive deficit on everyday life in schizophrenia could be questioned.

Indexed as

antipsychotic medicationcognitive deficitfirst psychotic episodeglobal functioningquality of lifeschizophrenia spectrum disorderverbal functionsvisuospatial functions

Identifiers

PMID26733828
PMCPMC4683173
OpenAlexW2217799529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.